Disposition of 3113 shares by Deck Kelly of InhibrxInc at 10.52 subject to Rule 16b-3

INBX Stock  USD 34.06  0.03  0.09%   
Slightly above 53% of InhibrxInc's investor base is interested to short. The analysis of the overall investor sentiment regarding InhibrxInc suggests that many traders are impartial. InhibrxInc's investor sentiment overview provides quick insight into current market opportunities from investing in InhibrxInc. The current market sentiment, together with InhibrxInc's historical and current headlines, can help investors time the market. In addition, many technical investors use InhibrxInc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
InhibrxInc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of InhibrxInc daily returns and investor perception about the current price of InhibrxInc as well as its diversification or hedging effects on your existing portfolios.
  
Filed transaction by InhibrxInc Officer: Chief Financial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at macroaxis.com
Disposition of 3113 stock option (right to buy) at 10.52 of InhibrxInc by Deck Kelly on 21st of March 2024. This event was filed by InhibrxInc with SEC on 2024-03-21. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

InhibrxInc's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the InhibrxInc's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

InhibrxInc Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards InhibrxInc can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

InhibrxInc Fundamental Analysis

We analyze InhibrxInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of InhibrxInc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of InhibrxInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Number Of Shares Shorted

Number Of Shares Shorted Comparative Analysis

InhibrxInc is currently under evaluation in number of shares shorted category among related companies. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

InhibrxInc Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with InhibrxInc stock to make a market-neutral strategy. Peer analysis of InhibrxInc could also be used in its relative valuation, which is a method of valuing InhibrxInc by comparing valuation metrics with similar companies.

Peers

InhibrxInc Related Equities

ELYMEliem Therapeutics   17.40   
0%
100.0%
HOWLWerewolf Therapeutics   8.70   
0%
50.0%
STOKStoke Therapeutics   6.16   
0%
35.0%
ANEBAnebulo Pharmaceuticals   2.95   
0%
16.0%
ELVNEnliven Therapeutics   2.38   
0%
13.0%
KRONKronos BioInc   2.04   
0%
11.0%
PTGXProtagonist Therapeutics   1.99   
0%
11.0%
LRMRLarimar Therapeutics   1.74   
0%
10.0%
VRDNViridian Therapeutics   1.42   
0%
8.0%
CELCCelcuity LLC   0.95   
0%
5.0%
DSGNDesign Therapeutics   0.53   
0%
3.0%
MRUSMerus BV   0.24   
0%
1.0%
MACKMerrimack Pharmaceuticals   0.14   
0%
1.0%
CRNXCrinetics Pharmaceuticals   0.40   
2.0%
0%
IKNAIkena Oncology   0.76   
4.0%
0%
LYELLyell Immunopharma   1.36   
7.0%
0%
GLUEMonte Rosa   2.20   
12.0%
0%
MLYSMineralys Therapeutics   2.82   
16.0%
0%
OPTOpthea   6.34   
36.0%
0%
When determining whether InhibrxInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of InhibrxInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inhibrxinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inhibrxinc Stock:
Check out InhibrxInc Hype Analysis, InhibrxInc Correlation and InhibrxInc Performance.
For more information on how to buy InhibrxInc Stock please use our How to Invest in InhibrxInc guide.
Note that the InhibrxInc information on this page should be used as a complementary analysis to other InhibrxInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for InhibrxInc Stock analysis

When running InhibrxInc's price analysis, check to measure InhibrxInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InhibrxInc is operating at the current time. Most of InhibrxInc's value examination focuses on studying past and present price action to predict the probability of InhibrxInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InhibrxInc's price. Additionally, you may evaluate how the addition of InhibrxInc to your portfolios can decrease your overall portfolio volatility.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Commodity Directory
Find actively traded commodities issued by global exchanges
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Is InhibrxInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InhibrxInc. If investors know InhibrxInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InhibrxInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.12)
Revenue Per Share
0.038
Quarterly Revenue Growth
4.964
Return On Assets
(0.46)
Return On Equity
(4.75)
The market value of InhibrxInc is measured differently than its book value, which is the value of InhibrxInc that is recorded on the company's balance sheet. Investors also form their own opinion of InhibrxInc's value that differs from its market value or its book value, called intrinsic value, which is InhibrxInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InhibrxInc's market value can be influenced by many factors that don't directly affect InhibrxInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InhibrxInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if InhibrxInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InhibrxInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.